Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Kramer

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|March 19, 2002
Underuse of aspirin in a referral population with documented coronary artery diseaseRobert M Califf, Elizabeth R DeLong, Truls Ostbye, et al.
Circulation|January 13, 2006
Long-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseL Kristin Newby, Nancy M Allen LaPointe, Anita Y Chen, et al.
Archives of Internal Medicine|March 12, 2008
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarctionDavid H Smith, Judith M Kramer, Nancy Perrin, et al.
The American Journal of Cardiology|May 4, 2002
Patient-reported frequency of taking aspirin in a population with coronary artery diseaseNancy M Allen LaPointe, Judith M Kramer, Elizabeth R DeLong, et al.
European Journal of Heart Failure|May 30, 2002
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failureMonica R Shah, Vic Hasselblad, Sandra S Stinnett, et al.
American Heart Journal|August 15, 2002
Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in womenWarren J Cantor, Julie M Miller, Anne S Hellkamp, et al.
Plos One|February 6, 2013
Using central IRBs for multicenter clinical trials in the United StatesKathryn E Flynn, Cynthia L Hahn, Judith M Kramer, et al.
American Heart Journal|July 29, 2008
Postmarket evaluation of breakthrough technologiesSunil V Rao, Robert M Califf, Judith M Kramer, et al.
Clinical Trials (London, England)|July 7, 2011
Monitoring the quality of conduct of clinical trials: a survey of current practicesBriggs W Morrison, Chrissy J Cochran, Jennifer Giangrande White, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine StudyPriscilla Velentgas, Rhonda L Bohn, Jeffrey S Brown, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|March 19, 2002
Underuse of aspirin in a referral population with documented coronary artery diseaseRobert M Califf, Elizabeth R DeLong, Truls Ostbye, et al.
Circulation|January 13, 2006
Long-term adherence to evidence-based secondary prevention therapies in coronary artery diseaseL Kristin Newby, Nancy M Allen LaPointe, Anita Y Chen, et al.
Archives of Internal Medicine|March 12, 2008
A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarctionDavid H Smith, Judith M Kramer, Nancy Perrin, et al.
The American Journal of Cardiology|May 4, 2002
Patient-reported frequency of taking aspirin in a population with coronary artery diseaseNancy M Allen LaPointe, Judith M Kramer, Elizabeth R DeLong, et al.
European Journal of Heart Failure|May 30, 2002
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failureMonica R Shah, Vic Hasselblad, Sandra S Stinnett, et al.
American Heart Journal|August 15, 2002
Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in womenWarren J Cantor, Julie M Miller, Anne S Hellkamp, et al.
Plos One|February 6, 2013
Using central IRBs for multicenter clinical trials in the United StatesKathryn E Flynn, Cynthia L Hahn, Judith M Kramer, et al.
American Heart Journal|July 29, 2008
Postmarket evaluation of breakthrough technologiesSunil V Rao, Robert M Califf, Judith M Kramer, et al.
Clinical Trials (London, England)|July 7, 2011
Monitoring the quality of conduct of clinical trials: a survey of current practicesBriggs W Morrison, Chrissy J Cochran, Jennifer Giangrande White, et al.
Pharmacoepidemiology and Drug Safety|October 29, 2008
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine StudyPriscilla Velentgas, Rhonda L Bohn, Jeffrey S Brown, et al.
Pageof 5